Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
C-Ray Therapeutics (Shanghai) Co., Ltd. Presents Breakthrough Clinical Data of Novel Targeted Alpha Therapy 225Ac-PSMA-CY313 at EANM 2025 2025-10-08 22:20
POMDOCTOR LIMITED Announces Pricing of Initial Public Offering 2025-10-08 20:00
Hope Medicine Inc. Announces Successful Completion of a Global Phase 2 Study of a Potential First-in-Class Endometriosis Treatment 2025-10-08 09:08
New White Paper by APAC CVD Alliance and Deloitte Charts Path to Tackle Rising Heart Failure Burden in Asia-Pacific 2025-10-08 09:00
CARsgen Presents Results on GPRC5D CAR-T CT071 in The Lancet Haematology 2025-10-08 08:15
Kazia Therapeutics Announces Collaboration and In-Licensing Agreement for First-in-Class PD-L1 Protein Degrader Program 2025-10-07 20:30
FDA Lifts Clinical Hold on NUZ-001 2025-10-06 14:06
MedHub-AI Announces National Reimbursement Approval in Japan for AutocathFFR™ 2025-10-03 07:00
Celltrion launches AVTOZMA® (tocilizumab-anoh) intravenous (IV) formulation in the United States 2025-10-02 20:30
Lundbeck to showcase amlenetug Phase 3 MASCOT trial design in Multiple System Atrophy at the International Congress of Parkinson's Disease and Movement Disorders® 2025 2025-10-02 16:41
MD Logistics Makes Largest Indiana Business Location Fully cGMP-compliant 2025-10-01 15:00
Major Health Management Wins the 2025 Health Brand Awards - Excellence Award in Health Technology (Health Examination Platform): 38 Years of Quality Commitment, Transforming into a Leading Health Technology Pioneer 2025-10-01 14:51
TAHO Pharma Announces Submission of New Drug Application (NDA) to the U.S. FDA for TAH3311 - The World's First Apixaban Oral Dissolving Film - Represents a Transformational Advancement in Anticoagulant Therapy 2025-10-01 14:16
Telix Announces Record-Breaking Presence at EANM 2025 2025-10-01 13:57
Novartis Singapore and the Singapore Heart Foundation Launch 'Beat the Block' Campaign to Raise Awareness of High Blood Cholesterol 2025-09-30 10:00
Johnson & Johnson Launches "Dual Control" Campaign in Asia Pacific to Empower Patients with IBD to Balance Disease Management and Dreams 2025-09-30 10:00
Full-Life Technologies Announces US$77 Million Financing to Accelerate Development of its Radiopharmaceutical Pipeline and Manufacturing Capabilities 2025-09-30 08:00
Health Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences 2025-09-29 20:48
Hanmi's Oral Delivery Platform Compound Licensed to Gilead 2025-09-29 17:45
Viva Biotech Receives Frost & Sullivan's 2025 APAC Technology Innovation Leadership Recognition in the Integrated Intelligent Drug Discovery Industry 2025-09-29 17:00
1 14 15 16 17 18 481